Disclaimer as of 16 March 2022

The data relating to ALIVER described on the EC website should be considered a “preliminary analysis”’ and although it is based on a fully audited and monitored Clinical Study Report, it has not been fully peer reviewed and therefore not published. Further details on the ALIVER clinical study outcomes can be found on https://yaqrit.com/news/the-aliver-consortium-announces-positive-results-from-phase-2-equivalent-trial-of-the-novel-liver-dialysis-device-dialive/ with details of the clinical study protocol on the ClinicalTrials.gov website https://www.clinicaltrials.gov/ct2/show/NCT03065699 and a copy of the Clinical Study Report is available on request from the Sponsor: Yaqrit Limited (www.yaqrit.com)